주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기
통합검색
로그인
고객센터
주요메뉴
질환포커스
세계의약뉴스
메디컬포커스
컨퍼런스
CME
근골격계
남성건강
내분비대사계
면역계
비뇨기계
심혈관계
여성건강
종양
호흡기계
감각기관계
중추신경계
소화기계
감염계
혈액 및 조혈계
최근 해외학술대회의 주요 발표내용을 제공합니다.
컨퍼런스 커버리지
ESHRE Virtual 37th Annual Meeting
26 June - 01 July, 2021, Belgium
Alcohol intake may reduce ability to conceive
2021-12-17
Even moderate alcohol intake, particularly during the second half of the menstrual cycle, should be avoided by women who want to get pregnant, according to a new study that was touted as the first to look at fecundability during the menstrual cycle phases.
Artificial cycle frozen-thawed embryo transfer may up preeclampsia, hypertension risk
2021-12-17
Women who undergo artificial cycle frozen-thawed embryo transfer (AC-FET) may have an elevated risk of preeclampsia and pregnancy-induced hypertension (PIH) compared with women who undergo ovulatory cycle frozen-thawed embryo transfer (OC-FET) or in vitro fertilization-fresh transfer (fresh-ET), according to a nationwide cohort study from France presented at ESHRE 2021.
COVID-19 infection unlikely to hinder IVF success
2021-12-17
COVID-19 infection does not appear to adversely affect ovarian reserve, and thus, the chance of success from assisted reproductive treatment likely remains the same as before infection, suggests a small study presented at ESHRE 2021.
Linzagolix maintains long-term benefit in women with uterine fibroids
2021-12-17
Linzagolix treatment continues to reduce menstrual blood loss (MBL) and pain severity, while improving haemoglobin (Hb) level and quality of life (QoL) up to 52 weeks in women with uterine fibroids,
according to two phase III
randomized clinical trials
presented at ESHRE 2021.
No increased cancer risk in ART-conceived children
2021-12-17
The risk of cancer is not elevated in children and young adults who were conceived after assisted reproductive technology (ART), including
in vitro
fertilization (IVF), intracytoplasmic sperm injection (ICSI), and fresh or frozen embryo transfer, compared with those conceived naturally, according to a study presented at ESHRE 2021.
OTC painkiller use during pregnancy tied to adverse infant outcomes
2021-12-17
Use of over-the-counter (OTC) painkillers during pregnancy is associated with an increased risk of adverse neonatal outcomes, suggests a large retrospective study presented at ESHRE 2021.
Reduction in endometriosis-associated pain sustained with relugolix combo therapy
2021-12-17
The combination of relugolix 40 mg plus oestradiol 1 mg and norethindrone acetate 0.5 mg (relugolix-CT) continued to reduce dysmenorrhoea and non-menstrual pelvic pain (NMPP) through 52 weeks in premenopausal women with endometriosis, according to the SPIRIT extension* study presented at ESHRE 2021.
Short delay in IVF start may not affect live birth rates
2021-12-17
A delay of up to 180 days in initiating in vitro fertilization (IVF) does not appear to affect live birth rates among women with infertility and diminished ovarian reserve, according to a retrospective cohort study presented at ESHRE 2021.
Survey says ? there’s little evidence of efficacy for fertility add-ons
2021-12-17
A retrospective study of IVF* patients in Australia reveals that 82 percent of women have used one or more fertility add-ons despite limited evidence of efficacy.
Tri-component lifestyle intervention benefits women with PCOS
2021-12-17
A three-component lifestyle intervention (LSI) programme* was effective in improving the metabolic health and weight of reproductive-aged women with polycystic ovarian syndrome (PCOS), according to data presented at ESHRE 2021.
1
최근 본 콘텐츠
최근 본 콘텐츠가 없습니다
관심제품
관심콘텐츠
